Colgate-Palmolive Company (NYSE:CL) is included among the 13 Best January Dividend Stocks to Invest in. Colgate-Palmolive (CL) Remains Overweight as JPMorgan Sees Headwinds Easing in 2026 On December 18, JPMorgan raised its price target on Colgate-Palmolive Company (NYSE:CL) to $88 from $87 and kept an Overweight rating as part of its 2026 outlook. The firm said the setup heading into 2026 for beverages, household, and personal care remains difficult. JPMorgan still expects results to improve as “many he ...

Core Insights - Nova Leap Health Corp. has promoted Melissa Anderson to Senior Vice President (U.S.) effective January 1, 2026, recognizing her contributions to the company's U.S. operations since joining in 2018 [1][2][3] Company Overview - Nova Leap is a healthcare services company focused on home-based and community-based care across North America, providing personal care, dementia care, and companion services [4] - The company has launched a Care Management division to offer coordinated, technology-enabled support for families navigating complex medical, cognitive, and social needs [4] Leadership and Growth Strategy - Melissa Anderson's promotion reflects her strong performance and the increasing complexity of Nova Leap's U.S. business, which is expanding through new locations, acquisitions, and additional service lines [2][3] - The company is committed to disciplined growth, including targeted acquisitions and de novo expansion supported by scalable infrastructure [3][4]

Dollar General Corporation (NYSE:DG) ranks among the best performing retail stocks in 2025. Guggenheim reaffirmed its $125 price target and Buy rating on Dollar General Corporation (NYSE:DG) on November 28 in anticipation of the retailer’s impending third-quarter earnings announcement. As Dollar General prepares to release its results on December 4, Guggenheim states that it expects “solid, potentially above-consensus” third-quarter earnings and a tightened yet elevated full-year guidance. Pixabay/Public ...

Core Viewpoint - Natural Health Trends Corp. will report its third quarter financial results on November 5, 2025, at 9:00 a.m. Eastern Time, followed by a conference call at 11:30 a.m. Eastern Time to discuss the results [1]. Company Overview - Natural Health Trends Corp. is a leading international direct-selling and e-commerce company that markets premium quality personal care, wellness, and "quality of life" products under the NHT Global brand [3]. - The company operates through subsidiaries across Asia, the Americas, and Europe [3]. Conference Call Details - The conference call to discuss the third quarter 2025 financial results is scheduled for November 5, 2025, at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time [2]. - Dial-in number for the conference call is 1-800-330-6730, with participant ID 236986 [2]. - A replay of the call will be available on the Company's Investor Relations website for those unable to participate live [2].

Group 1 - Dollar General Corporation (NYSE:DG) is considered one of the best FMCG stocks to invest in, with an 'Outperform' rating and a price target of $139 set by Wolfe Research analyst Spencer Hanus [1][2] - The bullish outlook is attributed to the stock's previous underperformance relative to the sector, with signs of operational improvement indicating a potential shift in favor of the discount retailer [2][3] - Current performance estimates for Dollar General are viewed as too low, and the stock's valuation is seen as compelling after years of underperformance, coinciding with a strong back-to-school purchasing trend benefiting retailers [3][4] Group 2 - Dollar General operates a chain of neighborhood retail stores that provide affordable everyday essentials, including food, cleaning supplies, personal care, and health items, primarily serving rural and smaller communities [4]

Core Viewpoint - The consumer staples sector has performed well, but Clorox has struggled, with its stock down 19% year-to-date, indicating potential investment opportunities despite challenges [1][3]. Company Challenges - Clorox has faced several challenges, including noncash impairment charges, a costly cyberattack, and difficulties in managing supply chains amid economic uncertainty and high inflation [3]. - The transition to a cloud-based ERP system has added costs but is expected to improve efficiency starting in 2026 [4]. Financial Performance - Clorox has shown improvement with 10 consecutive quarters of gross margin expansion, recovering from a significant drop in 2022 due to overestimating pandemic demand [5][6]. - Despite recent challenges, Clorox expects strong fiscal 2025 earnings guidance of $5.73 to $6.13, indicating a low P/E ratio of 19 based on the lower end of its adjusted range [11]. Strategic Outlook - Clorox's IGNITE strategy aims to enhance its product portfolio and internal operations while considering environmental, social, and governance factors [13]. - The company has a solid foundation with a lineup of category-leading brands, positioning it for future growth [13]. Dividend and Valuation - Clorox has a dividend yield of 3.7%, significantly higher than the broader consumer staples sector's 2.4%, showcasing its value for passive income [15][14]. - The company's dividend yield is currently inflated compared to its historical average due to stock price declines [17]. Investment Recommendation - Clorox is considered a strong buy for risk-averse investors seeking reliable dividend income, with expectations for sustained higher margins despite macroeconomic challenges [18].

Core Viewpoint - Natural Health Trends Corp. reported a 2% year-over-year revenue decrease for Q1 2025, attributed to promotional calendar differences, but showed a 9% sequential increase in orders from Q4 2024, indicating strong customer interest in their products [4][8]. Financial Performance - Revenue for Q1 2025 was $10.7 million, down from $11.0 million in Q1 2024, marking a 2% decline [9]. - The operating loss was $345,000, an improvement from a loss of $365,000 in the same quarter of the previous year [9]. - Net income for Q1 2025 was $122,000, or $0.01 per diluted share, compared to $188,000, or $0.02 per diluted share, in Q1 2024 [9]. - Active Members decreased by 2% to 30,180 as of March 31, 2025, compared to 30,870 at December 31, 2024, and down 5% from 31,620 at March 31, 2024 [9]. Cash Flow and Dividends - Cash flows from operations were $484,000 in Q1 2025, down from $549,000 in Q1 2024 [10]. - The company declared a quarterly cash dividend of $0.20 per share, payable on May 23, 2025 [10]. Balance Sheet Overview - Total cash, cash equivalents, and marketable securities were $41.9 million at March 31, 2025, down from $43.9 million at December 31, 2024 [10]. - Total assets decreased to $53.2 million as of March 31, 2025, from $55.4 million at December 31, 2024 [15][16]. Management Commentary - Management acknowledged the challenges posed by the ongoing trade war and emphasized efforts to align manufacturing closer to key markets to enhance efficiency [5]. - The company remains committed to delivering high-quality products and exceptional service to improve the well-being of its members [5].